The sigma-1 receptor enhances brain plasticity and functional recovery after experimental stroke

Brain

Volumn 134, Issue 3, 2011, Pages 732-746

  Ruscher, Karsten ^a   Shamloo, Mehrdad ^b,c   Rickhag, Mattias ^a   Ladunga, Istvan ^b,d   Soriano, Liza ^b   Gisselsson, Lennart ^a   Toresson, Hkan ^a   Ruslim Litrus, Lily ^b   Oksenberg, Donna ^b   Urfer, Roman ^b,e   Johansson, Barbro B ^a   Nikolich, Karoly ^b,c   Wieloch, Tadeusz ^a  

^a LUND UNIVERSITY   (Sweden)

^b AGY Therapeutics Inc   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF NEBRASKA LINCOLN   (United States)

^e M'S Science Corporation   (United States)

Author keywords

astrocyte; membrane raft; neurite outgrowth; sigma 1 receptor; stroke recovery

Indexed keywords

CUTAMESINE; GALACTOSYLCERAMIDASE; NEUREXIN; SIGMA 1 OPIATE RECEPTOR; SPINOPHILIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; BRAIN INFARCTION SIZE; CELL TRANSPORT; CONTROLLED STUDY; GENE SILENCING; MIDDLE CEREBRAL ARTERY OCCLUSION; NERVE CELL PLASTICITY; NERVE GROWTH; NERVE STIMULATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SENSORIMOTOR FUNCTION; STROKE;

ANIMALS; ASTROCYTES; BRAIN; CAVEOLIN 1; CELL HYPOXIA; CELLS, CULTURED; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENVIRONMENT; GENE EXPRESSION REGULATION; GLUCOSE; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; MOVEMENT; NEURITES; NEURONAL PLASTICITY; NEURONS; NOOTROPIC AGENTS; PIPERAZINES; PROTEIN TRANSPORT; PSYCHOMOTOR PERFORMANCE; RATS; RATS, INBRED SHR; RECEPTORS, SIGMA; RECOVERY OF FUNCTION; RNA, SMALL INTERFERING; STATISTICS, NONPARAMETRIC; TRANSFECTION;

EID: 79952126094     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awq367     Document Type: Article

References (60)

1. Barbay S, Nudo RJ. The effects of amphetamine on recovery of function in animal models of cerebral injury: a critical appraisal. NeuroRehabilitation 2009;25:5-17.
2. Bhardwaj A, Sawada M, London ED, Koehler RC, Traystman RJ, Kirsch JR. Potent sigma1-receptor ligand 4-phenyl-1-(4-phenylbutyl) piperidine modulates basal and N-methyl-D-aspartate-evoked nitric oxide production in vivo. Stroke 1998;29:2404-10.
3. Brown CE, Wong C, Murphy TH. Rapid morphologic plasticity of peri-infarct dendritic spines after focal ischemic stroke. Stroke 2008;39:1286-91. (Pubitemid 351440703)
4. Buga AM, Dunoiu C, Balseanu A, Popa-Wagner A. Cellular and molecular mechanisms underlying neurorehabilitation after stroke in aged subjects. Rom J Morphol Embryol 2008;49:279-302.
5. Bush TG, Puvanachandra N, Horner CH, Polito A, Ostenfeld T, Svendsen CN, et al. Leukocyte infiltration, neuronal degeneration, and neurite outgrowth after ablation of scar-forming, reactive astrocytes in adult transgenic mice. Neuron 1999;23:297-308. (Pubitemid 29315725)
6. Carmichael ST, Archibeque I, Luke L, Nolan T, Momiy J, Li S. Growthassociated gene expression after stroke: evidence for a growthpromoting region in peri-infarct cortex. Exp Neurol 2005;193:291-311. (Pubitemid 40616180)
7. Chandra S, White RF, Everding D, Feuerstein GZ, Coatney RW, Sarkar SK, et al. Use of diffusion-weighted MRI and neurological deficit scores to demonstrate beneficial effects of isradipine in a rat model of focal ischemia. Pharmacology 1999;58:292-9. (Pubitemid 29206184)
8. Chen P, Goldberg DE, Kolb B, Lanser M, Benowitz LI. Inosine induces axonal rewiring and improves behavioral outcome after stroke. Proc Natl Acad Sci USA 2002;99:9031-6. (Pubitemid 34693678)
9. Chichili GR, Rodgers W. Clustering of membrane raft proteins by the actin cytoskeleton. J Biol Chem 2007;282:36682-91.
10. Dancause N, Barbay S, Frost SB, Plautz EJ, Chen D, Zoubina EV, et al. Extensive cortical rewiring after brain injury. J Neurosci 2005;25:10167-79. (Pubitemid 41636213)
11. Dean C, Scholl FG, Choih J, DeMaria S, Berger J, Isacoff E, et al. Neurexin mediates the assembly of presynaptic terminals. Nat Neurosci 2003;6:708-16. (Pubitemid 36792885)
12. Delacour D, Jacob R. Apical protein transport. Cell Mol Life Sci 2006;63:2491-505. (Pubitemid 44722380)
13. Dun Y, Thangaraju M, Prasad P, Ganapathy V, Smith SB. Prevention of excitotoxicity in primary retinal ganglion cells by (+)-pentazocine, a sigma receptor-1 specific ligand. Invest Ophthalmol Vis Sci 2007;48:4785-94. (Pubitemid 351260999)
14. Duncan PW, Lai SM, Keighley J. Defining post-stroke recovery: implications for design and interpretation of drug trials. Neuropharmacology 2000;39:835-41. (Pubitemid 30103686)
15. Endres M, Engelhardt B, Koistinaho J, Lindvall O, Meairs S, Mohr JP, et al. Improving outcome after stroke: overcoming the translational roadblock. Cerebrovasc Dis 2008;25:268-78. (Pubitemid 351450431)
16. Gisselsson LL, Matus A, Wieloch T. Actin redistribution underlies the sparing effect of mild hypothermia on dendritic spine morphology after in vitro ischemia. J Cereb Blood Flow Metab 2005;25:1346-55. (Pubitemid 41348736)
17. Gonzenbach RR, Schwab ME. Disinhibition of neurite growth to repair the injured adult CNS: focusing on Nogo. Cell Mol Life Sci 2008;65:161-76.
18. Goyagi T, Bhardwaj A, Koehler RC, Traystman RJ, Hurn PD, Kirsch JR. Potent sigma 1-receptor ligand 4-phenyl-1-(4-phenylbutyl) piperidine provides ischemic neuroprotection without altering dopamine accumulation in vivo in rats. Anesth Analg 2003;96:532-8. (Pubitemid 36125778)
19. Guirland C, Suzuki S, Kojima M, Lu B, Zheng JQ. Lipid rafts mediate chemotropic guidance of nerve growth cones. Neuron 2004;42:51-62. (Pubitemid 38456967)
20. Hall A. Rho GTPases and the control of cell behaviour. Biochem Soc Trans 2005;33:891-5. (Pubitemid 41659073)
21. Hayashi T, Su TP. Regulating ankyrin dynamics: roles of sigma-1 receptors. Proc Natl Acad Sci USA 2001;98:491-6. (Pubitemid 32105069)
22. Hayashi T, Su TP. Sigma-1 receptors (sigma (1) binding sites) form raft-like microdomains and target lipid droplets on the endoplasmic reticulum: roles in endoplasmic reticulum lipid compartmentalization and export. J Pharmacol Exp Ther 2003;306:718-25. (Pubitemid 36886173)
23. 2+) signaling and cell survival. Cell 2007;131:596-610. (Pubitemid 350017760)
24. Hering H, Lin CC, Sheng M. Lipid rafts in the maintenance of synapses, dendritic spines, and surface AMPA receptor stability. J Neurosci 2003;23:3262-71. (Pubitemid 36531967)
25. Hernandez TD, Schallert T. Seizures and recovery from experimental brain damage. Exp Neurol 1988;102:318-24. (Pubitemid 19005595)
26. Hummel F, Celnik P, Giraux P, Floel A, Wu WH, Gerloff C, et al. Effects of non-invasive cortical stimulation on skilled motor function in chronic stroke. Brain 2005;128:490-9. (Pubitemid 40380185)
27. Johansson BB. Functional and cellular effects of environmental enrichment after experimental brain infarcts. Restor Neurol Neurosci 2004;22:163-74. (Pubitemid 39468278)
28. Johansson BB, Belichenko PV. Neuronal plasticity and dendritic spines: effect of environmental enrichment on intact and postischemic rat brain. J Cereb Blood Flow Metab 2002;22:89-96. (Pubitemid 34038387)
29. Johansson BB, Ohlsson AL. Environment, social interaction, and physical activity as determinants of functional outcome after cerebral infarction in the rat. Exp Neurol 1996;139:322-7. (Pubitemid 26228100)
30. Katnik C, Guerrero WR, Pennypacker KR, Herrera Y, Cuevas J. Sigma-1 receptor activation prevents intracellular calcium dysregulation in cortical neurons during in vitro ischemia. J Pharmacol Exp Ther 2006;319:1355-65.
31. Keyvani K, Sachser N, Witte OW, Paulus W. Gene expression profiling in the intact and injured brain following environmental enrichment. J Neuropathol Exp Neurol 2004;63:598-609. (Pubitemid 38736423)
32. Koganemaru S, Mima T, Thabit MN, Ikkaku T, Shimada K, Kanematsu M, et al. Recovery of upper-limb function due to enhanced use-dependent plasticity in chronic stroke patients. Brain 2010;133:3373-84, doi:10.1093/brain/awq193.
33. Lee JK, Kim JE, Sivula M, Strittmatter SM. Nogo receptor antagonism promotes stroke recovery by enhancing axonal plasticity. J Neurosci 2004;24:6209-17. (Pubitemid 38891112)
34. Li L, Lundkvist A, Andersson D, Wilhelmsson U, Nagai N, Pardo AC, et al. Protective role of reactive astrocytes in brain ischemia. J Cereb Blood Flow Metab 2008;28:468-81. (Pubitemid 351304260)
35. Majewska A, Tashiro A, Yuste R. Regulation of spine calcium dynamics by rapid spine motility. J Neurosci 2000;20:8262-8.
36. Martina M, Turcotte ME, Halman S, Bergeron R. The sigma-1 receptor modulates NMDA receptor synaptic transmission and plasticity via SK channels in rat hippocampus. J Physiol 2007;578:143-57. (Pubitemid 44971116)
37. Matsuno K, Senda T, Kobayashi T, Okamoto K, Nakata K, Mita S. SA4503, a novel cognitive enhancer, with sigma 1 receptor agonistic properties. Behav Brain Res 1997;83:221-4. (Pubitemid 27086643)
38. Memezawa H, Minamisawa H, Smith ML, Siesjo BK. Ischemic penumbra in a model of reversible middle cerebral artery occlusion in the rat. Exp Brain Res 1992;89:67-78.
39. Meunier J, Hayashi T. Sigma-1 receptors regulate Bcl-2 expression by ROS-dependent transcriptional regulation of NF-kB. J Pharmacol Exp Ther 2010;332:388-97.
40. Murphy TH, Corbett D. Plasticity during stroke recovery: from synapse to behaviour. Nat Rev Neurosci 2009;10:861-72.
41. Nedergaard M, Dirnagl U. Role of glial cells in cerebral ischemia. Glia 2005;50:281-286. (Pubitemid 40780834)
42. Nudo RJ. Postinfarct cortical plasticity and behavioral recovery. Stroke 2007;38:840-5. (Pubitemid 46184268)
43. Ohlsson AL, Johansson BB. Environment influences functional outcome of cerebral infarction in rats. Stroke 1995;26:644-9.
44. Orioli D, Colaluca IN, Stefanini M, Riva S, Dotti CG, Peverali FA. Rac3-induced neuritogenesis requires binding to Neurabin I. Mol Biol Cell 2006;17:2391-400. (Pubitemid 44011753)
45. Palmer CP, Mahen R, Schnell E, Djamgoz MB, Aydar E. Sigma-1 receptors bind cholesterol and remodel lipid rafts in breast cancer cell lines. Cancer Res 2007;67:11166-75. (Pubitemid 350248541)
46. Pelkmans L, Kartenbeck J, Helenius A. Caveolar endocytosis of simian virus 40 reveals a new two-step vesicular-transport pathway to the ER. Nat Cell Biol 2001;3:473-83. (Pubitemid 32422083)
47. Potokar M, Kreft M, Li L, Daniel Andersson J, Pangrsic T, Chowdhury HH, et al. Cytoskeleton and vesicle mobility in astrocytes. Traffic 2007;8:12-20. (Pubitemid 44921879)
48. Rickhag M, Deierborg T, Patel S, Ruscher K, Wieloch T. Apolipoprotein D is elevated in oligodendrocytes in the peri-infarct region after experimental stroke: influence of enriched environment. J Cereb Blood Flow Metab 2008;28:551-62. (Pubitemid 351304266)
49. Rickhag M, Wieloch T, Gidö G, Elmér E, Krogh M, Murray J, et al. Comprehensive regional and temporal gene expression profiling of the rat brain during the first 24 h after experimental stroke identifies dynamic ischemia-induced gene expression patterns, and reveals a biphasic activation of genes in surviving tissue. J Neurochem 2006;96:14-29.
50. Ruscher K, Freyer D, Karsch M, Isaev N, Megow D, Sawitzki B, et al. Erythropoietin is a paracrine mediator of ischemic tolerance in the brain: evidence from an in vitro model. J Neurosci 2002;22:10291-301. (Pubitemid 35416867)
51. Ruscher K, Johannesson E, Brugiere E, Erickson A, Rickhag M, Wieloch T. Enriched environment reduces apolipoprotein E (ApoE) in reactive astrocytes and attenuates inflammation of the peri-infarct tissue after experimental stroke. J Cereb Blood Flow Metab 2009;29:1796-805.
52. Schneider A, Wysocki R, Pitzer C, Krüger C, Laage R, Schwab S, et al. An extended window of opportunity for G-CSF treatment in cerebral ischemia. BMC Biol 2006;4:36.
53. Sofroniew MV. Reactive astrocytes in neural repair and protection. Neuroscientist 2005;11:400-7. (Pubitemid 41339226)
54. STAIRS. Recommendations for standards regarding preclinical neuroprotective and restorative drug development. Stroke 1999;30:2752-8.
55. Swanson RA, Morton MT, Tsao-Wu G, Savalos RA, Davidson C, Sharp FR. A semiautomated method for measuring brain infarct volume. J Cereb Blood Flow Metab 1990;10:290-3. (Pubitemid 20096202)
56. Tashiro A, Yuste R. Regulation of dendritic spine motility and stability by Rac1 and Rho kinase: evidence for two forms of spine motility. Mol Cell Neurosci 2004;26:429-40. (Pubitemid 38968436)
57. Vance JE, Hayashi H, Karten B. Cholesterol homeostasis in neurons and glia cells. Sem Cell Dev Biol 2005;16:193-212. (Pubitemid 40432121)
58. Villa P, van Beek J, Larsen AK, Gerwien J, Christensen S, Cerami A, et al. Reduced functional deficits, neuroinflammation, and secondary tissue damage after treatment of stroke by nonerythropoietic erythropoietin derivatives. J Cereb Blood Flow Metab 2007;27:552-63.
59. Viola A, Gupta N. Tether and trap: regulation of membrane-raft dynamics by actin-binding proteins. Nat Rev Immunol 2007;7:889-96. (Pubitemid 350006240)
60. Wieloch T, Nikolich K. Mechanisms of neural plasticity following brain injury. Curr Opin Neurobiol 2006;16:258-64. (Pubitemid 43949227)